CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity.
Salehi-Rad R, Lim RJ, Du Y, Tran LM, Li R, Ong SL, Ling Huang Z, Dumitras C, Zhang T, Park SJ, Crosson W, Kahangi B, Abascal J, Seet C, Oh M, Shabihkhani M, Paul M, Krysan K, Lisberg AE, Garon EB, Liu B, Dubinett SM.
Salehi-Rad R, et al. Among authors: du y.
J Immunother Cancer. 2023 Sep;11(9):e006896. doi: 10.1136/jitc-2023-006896.
J Immunother Cancer. 2023.
PMID: 37730274
Free PMC article.